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Abstract
Introduction: The prevalence of obesity has increased at an im-
pressive rate over the past years, especially among children and ado-
lescents. Many are the alterations that may be found in obese indivi-
duals; hepatic steatosis is one of them. The aim of this study was to 
analyze biochemical and radiographic parameters in overweight and 
obese adolescents and relate these parameters to anthropometric 
data so that the hepatic dysfunction could be characterized.
Methods: Anthropometric and laboratory data, as well as the nu-
tritional status of the patients, were evaluated. Besides laboratory 
exams, a liver ultrasound scan was performed to confirm hepatic 
alterations.
Results: A total of 41 patients were recruited and 6 out of that 
total were excluded due to the fact they were eutrophic. The re-
maining group was compared with a control group of 12 patients. 
The overweight/obese group had higher values of AST and ALT in 
relation to the control group. There were no alterations associated 
with biochemical parameters regarding anthropometric variables. A 
significant difference between the BMI of patients with and without 
steatosis could be observed.
Conclusions: There was a predominance of hepatic steatosis in the 
overweight/obese group, which was associated with the increase in 
GGT and ALT levels.
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Introduction
Epidemiology
Over the past years the prevalence of obesity has 
increased at an impressive rate both in developed 
and developing countries. This fact has been alar-
ming health professionals owing to its epidemic 
proportions in certain areas along with its clinical 
repercussions, turning obesity into one of the major 
public health issues.
In the United States over one-third of the adult 
population and nearly 17% of the young popula-
tion are classified as obese [1]. In Brazil around one 
million children aged 10 years or under were obese 
in 1989, with prevalence of 2.5% of this total in 
low-income families and 8% in families with better 
socioeconomic status. In 1996 the obesity rate in 
the country was of 4.5% in children and 23% in 
adolescents. Today a great amount of studies on the 
prevalence of obesity can be found in the literature 
with astounding numbers [2].
The increase in the incidence of obesity can be 
observed not only among adults, but also among 
children and adolescents [3, 4, 5]. The highest risk 
for the establishment of obesity occurs during the 
first years of life of a child and during adolescence 
[6].
Hepatic steatosis is one of the many alterations 
that can be found in obese individuals. It is related 
to the body mass index (BMI), waist circumferen-
ce, hypertriglyceridemia, hyperinsulinemia, glu-
cose intolerance and diabetes [7]. Nonalcoholic 
steatohepatitis (NASH) is another obesity-related 
disease frequently associated with visceral fat ac-
cumulation. It is closely associated with hepatic 
fat and markers of insulin resistance syndrome 
[8, 9].
The prevalence of nonalcoholic steatohepatitis is 
around 3% in the general population, reaching ra-
tes of 20-40% in obese patients. The focus on this 
pathology is due to the fact it is a progressive fi-
brotic disease which may evolve to cirrhosis in 25% 
of the cases and lead 10% of the cases to death 
within a period of 10 years [10].
Considering the lack of data in the literature, this 
study proposes to investigate the hepatic repercus-
sions of obesity in adolescents by analyzing bioche-
mical and radiographic parameters in overweight 
and obese adolescents and relate these parameters 
to anthropometric data so that the hepatic dys-
function can be characterized.
Patients and methods
Study Design 
This is a retrospective study which included obese 
adolescents aged between 10 and 19 years and 
11 months from the ABC Medical School (FMABC) 
Healthcare Outpatient Clinic. All medical records 
between 1998 and 2003 were evaluated.
Inclusion Criteria:
•   Adolescents  of  both  sexes  aged  between  10 
and 19 years and 11 months;
•   adolescents  with  BMI  between  85  and  95 
(overweight) and above the 95th percentile 
(obese).
Exclusion Criteria:
•   Chronic  diseases:  cardiopathies,  endocrino-
pathies, nephropathies or neuropathies;
•   status of morbidity;
•   use of immunosuppressants six months prior to 
the beginning of the study.
Variables of Interest and Establishment of 
Groups
In order to identify obesity, the criteria of Must et 
al (1991) was used [20]:
•   low weight: below the 5th percentile;
•   eutrophic: between the 5th and 85th percentile;
•   overweight:  between  the  85th and 95th per-
centile;
•   obese: above the 95th percentile.
Control group was constituted of eutrophic pa-
tients.
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The current study was previously submitted to 
the Local Research Ethics Committee approval un-
der the number 094/2003.
The following variables were analyzed
1) Anthropometry: All patients were weighed in 
underwear and in bare feet on a portable Plenna 
MEA-08608 150 X 0.1 kg electronic scale. Height 
was obtained through an Alturexata stadiometer in 
centimeters. When measured, patients were bare-
foot, in the upright position and, in case of female 
patients, without hair accessories.
2) Body Composition: The brachial circumference 
was measured with a measuring tape in centime-
ters, and the triceps skinfold thickness (TS) was 
measured using a Lange skinfold caliper (Figure 
2), with a 0-60 mm scale, halfway between the 
olecranon process of the elbow the acromial pro-
cess of the scapula. The parameters found were 
analyzed with percentile calculations and classi-
fied, according to Frisancho's classification crite-
ria  (1990)  (11),  as  follows: patients who had bra-
chial circumference and triceps skinfold thickness 
values between the 90th and the 95th percentile 
(p90<TS<p95) were considered overweight; those 
with values above the 95th percentile (TS>95) were 
considered obese [11].
3) Nutritional State Classification: BMI was cal-
culated according to the height and weight data 
supplied (weight in kilograms/height in square me-
ters). As cut-off point reference standards, the cri-
teria of Must el al (1991) were applied. The cut-off 
points used were: p85 < BMI<p95 for overweight 
patients and BMI > p95 for obese patients [12].
4) Laboratory Evaluation: Laboratory evaluation 
included blood biochemical tests carried out at the 
Clinical Analyses Laboratory of FMABC.
•   Complete blood count, coagulogram, ALT, AST, 
gamma-glutamyl transferase, alkaline phospha-
tase, total bilirubin and fractions, total proteins 
and fractions, total cholesterol and fractions, 
triglycerides, insulin, fast glycemia, ferritin;
•   Liver ultrasound scan, performed with an HDI 
1500 ultrasound system, using a 3.5-5.0 MHz 
multifrequency convex transducer. All tests 
were carried out by the same professional. The 
parameter for the diagnosis of hepatic steatosis 
was the comparison with the renal cortex [13].
Statistical Analysis
At first all variables were analyzed descriptively. For 
quantitative variables the analysis was made through 
the observation of minimum and maximum values 
and the calculation of means, standard deviations 
and median. For qualitative variables absolute and 
relative frequencies were calculated.
Student's t test was used for the sake of compa-
rison of means between both groups; the non-pa-
rametric Mann-Whitney test was applied whenever 
the supposition of data normality was rejected.
When the supposition of data normality was re-
jected, the non-parametric Kruskal-Wallis test was 
used followed by Dunn's pair wise comparison.
In order to test the homogeneity between the 
proportions, the chi-square test was used, or the 
Fisher exact test when the expected frequencies 
were less than 5.
The multivariate logistic regression model was 
used to obtain factors associated with events. The 
significance level was set at p=0.05.
All tests were conducted using SPSS-10 software. 
Student's t test was applied to compare parametric 
variables; Mann-Whitney test was used to compare 
non-parametric variables. The significance level was 
established as p=0.05.
Results
At first a total of 41 patients were included in the 
overweight/obese group. From this amount, 6 pa-
tients were excluded due to the fact they were 
eutrophic, leaving a total of 35 individuals in the 
study -14 males and 21 females. Control group was 
composed of 12 patients- 5 males and 7 females.
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Table 1 shows the demographic characteristics of 
overweight/obese and control groups. A significant 
difference can be observed regarding the parame-
ters that characterize weight excess, such as BMI, 
weight in kilograms, brachial circumference and tri-
ceps skinfold thickness.
In Table 2 a significant difference in glycemia, insu-
lin and triglyceride values, higher in the overweight/
obese group than in the eutrophic group, can be 
observed. 
Table 3 separates patients with and without he-
patic steatosis. ALT and GGT values are higher in 
the steatosis group. On the other hand, this group 
had a mean BMI of 28.26 whereas this value in the 
non-steatosis group was of 23.34 kg, with signifi-
cance level of 0.014.
Table 1. Demographic characteristics of overweight/obese and control groups.
Variable BMI > 25 (n=35)   BMI < 25 (n=12) p
Age (years) 14.86 (2.56) 14.75 (2.18) 0.897
Sex:
Female (%)
-22,6 ± 41,3 0,55
Ethnic Group 
Caucasian (%)
23 (65.7) 7 (58.3) 0.650
Weight (kg) 77.47 (15.75) 51.39 (7.69) <0.001
Height 1.63 (9.59) 1.64 (0.11) 0.918
BMI 28.58(4.17) 19.15(1.70) <0.001
Brachial circumference (cm) 34.04(3.25) 25.54(2.62) <0.001
Triceps skinfold thickness (cm) 29.12(4.91) 15.17(6.89) <0.001
Table 2. Laboratory variables found in overweight/obese group and control.
Variables p
Hemoglobin (g/dl) 14.30 (1.35) 13.87(0.85) 0.305
Hematocrit (%) 43.46(4.24) 43.93(3.60) 0.731
Cholesterol 160.83(26.83) 148(19.55) 0.136
HDL 46.98(7.87) 44.59(11.19) 0.422
LDL 94.73(27.84) 87.51(14.52) 0.397
Triglycerides 100.97(45.45) 79.50(20.43) 0.032
Insulin 14.93(11.26) 7.83(2.88) 0.001
Glycemia 90.09(10.73) 79.75(5.55) <0.001
Glycemia/Insulin 7.94(3.31) 11.39(3.76) 0.004
Table 3. Laboratory variables found in the groups with and without hepatic steatosis.
Variables Hepatic Steatosis (n=22) Non-hepatic steatosis (n=25) p
Triglycerides 93.91 (45.85) 96.88 (7.6) 0.809
Cholesterol 159.05 (27.48) 156.24 (20.94) 0.712
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Discussion
The current study found a higher frequency of 
overweight/obesity than in other studies. In Silva 
et al (14), which included 211 adolescents, there 
was a prevalence rate of 6.2% of overweight and 
of 5.7% of obesity [14]. Such numbers draw the 
attention of health professionals since overweight 
rates in this series were higher for both sexes with 
a greater number of obese male patients. In their 
study with school children, Huang et al [15] show 
a prevalence rate of obesity in 18.5% of the boys 
and in 15% of the girls [15].
In a study with obese children and adolescents 
ranging from 5 to 14 years of age, Asayama et al 
(16) found levels of insulin significantly higher in the 
obese group when obese and non-obese groups 
were compared [16] 
Csábi et al, in a study with 180 obese children, 
found expressive differences in means of glycemia 
and insulin when compared with control group, a 
finding that complies with this study [17].
Concerning liver function tests, when overweight/
obese group was compared with control group, 
substantial differences were found regarding the 
means of AST, ALT, albumin and globulin despite 
the fact individual levels were within the normal 
range.
When hepatic steatosis was investigated, 21 pa-
tients with steatosis were found in the overweight/
obese group whereas only one in the control group, 
corroborating the literature on the subject [18].
A significant difference between the BMI of pa-
tients with and without steatosis could be noted. 
Studies with adults and children in the literature 
show a relation between higher rates of BMI and 
hepatic steatosis and higher levels of ALT with NASH 
[9, 18, 19, 20].
Such data lead to the assumption that patients 
from our sample are prone to develop NASH; the-
refore, multiprofessional guidance that includes 
medical, nutritional, psychological and physical 
activity advice should be supplied to these indi-
viduals.
When liver function tests of patients with stea-
tosis were analyzed, values of alkaline phosphata-
se, which were within the normal range, were not 
higher than those found in other studied series [9, 
19, 20].
HDL 47.28 (8.81) 45.57 (8.83) 0.510
LDL 94.70 (29.66) 91.30 (24.33) 0.649
Insulin (UI/ml) 16.13 (13.55) 10.46 (5.09) 0.076
Glycemia (mg/dl) 90.36 (12) 84.88 (8.73) 0.078
Glycemia/Insulin 8.27 (4.21) 9.31 (3.22) 0.345
Prothrombin (%) 96.82 (6.08) 96.20 (7.23) 0.880
TTPA 30.93 (4.66) 31.98 (6.52) 0.533
AST 21.95 (4.98) 19.68 (3.97) 0.080
ALT 18.82 (8.41) 13.96 (5.05) 0.024
GGT 20.41 (7.69) 15.44 (7.07) 0.026
Alkaline phosphatase 253.41 (156.51) 232.44 (114.31) 0.600
Albumin 4.15 (0.4) 4.40 (0.38) 0.030
Ferritin 43.79 (56.14) 31.21 (22.53) 0.308
HDL 46.98(7.87) 44.59(11.19) 0.422
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In relation to aminotransferases, only ALT va-
lues were increased. However, there are studies in 
the literature that show increases in AST and ALT 
levels, with predominance of the latter. A study 
on children and adolescents which evaluate BMI 
parameters of patients with hepatic steatosis show 
the association of ALT elevation with BMI increase 
and hepatic steatosis, which suggest the presence 
of NASH [18].
In a case report, Moleston et al [21] highlighted 
the association of two NASH male patients, aged 
10 and 12, with evolution to hepatic cirrhosis. They 
showed the presence of elevated aminotransferases 
in both boys, with prevalence of high levels of ALT. 
The liver ultrasound scan revealed steatosis and he-
patomegalia [21].
When Sanyal [9] compared healthy patients with 
steatosis and NASH patients, he did not find subs-
tantial differences of albumin concentrations in none 
of the three groups. Other studies involving NASH 
patients with mean values of albumin slightly higher 
than the ones found in this study can be found in 
the literature [9, 19 ,21, 22, 23, 24].
In conclusion, the predominance of hepatic 
steatosis in the overweight/obese group of pa-
tients in this series could be observed. This pre-
sence was associated with the increase of GGT 
and ALT levels.
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